MedPath

Remifentanil_ Propofol versus Remifentanil_ Ketamine in Diagnostic Bronchoscopy

Phase 2
Recruiting
Conditions
Sedation for Diagnostic Bronchoscopy.
Abnormal findings on diagnostic imaging of lung
Registration Number
IRCT20171202037716N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

18 to 65 y/o Patients with Pulmonary Diseases ( ASA : 1_3 ) that selected by Pulmonologist for Diagnostic Bronchoscopy

Exclusion Criteria

Patients with Opioid addiction
Untreated HTN or IHD
Loss of Consciousness
Epileptic Patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent of Systolic Blood Pressure Rising after Drugs administeration. Timepoint: Record of Systolic Blood Pressure Before, During and After Procedure. Method of measurement: Non invasive Manometer.
Secondary Outcome Measures
NameTimeMethod
Consciousness State of Patients. Timepoint: 10 minutes after end of Procedure. Method of measurement: Ramsey Sedation Score.
© Copyright 2025. All Rights Reserved by MedPath